Related Experiment Video
Updated: Jul 10, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Flap reconstruction and interstitial brachytherapy in nonextremity soft tissue sarcoma
Vineeta Goel1, Ashish Goel, Nitin Gupta
1Department of Radiation Oncology, Mahavir Cancer Sansthan, Patna-801 505, Bihar, India. vineetagoel@yahoo.com
Journal of Cancer Research and Therapeutics
|November 14, 2007
Summary
Interstitial brachytherapy can be safely used with flap reconstruction for recurrent high-grade soft tissue sarcomas. This approach offers advantages for patients requiring boost or radical doses after surgical excision.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- High-grade soft tissue sarcomas require multimodal treatment, often involving radiotherapy.
- Interstitial brachytherapy is a radiotherapy technique with advantages for delivering precise radiation doses.
- Concerns exist regarding the use of brachytherapy alongside flap reconstruction for skin defects post-surgery.
Observation:
- This study presents the initial experience of using interstitial brachytherapy in two patients.
- Patients had recurrent high-grade, non-extremity soft tissue sarcomas.
- Treatment involved surgical excision followed by soft tissue reconstruction and brachytherapy.
Findings:
- The study demonstrates the feasibility of combining interstitial brachytherapy with flap reconstruction.
- This approach was applied to patients with recurrent high-grade soft tissue sarcomas.
- Initial experience suggests this combined modality is a viable option for selected cases.
Implications:
- Interstitial brachytherapy may be a safe and effective option for managing recurrent soft tissue sarcomas requiring flap reconstruction.
- This technique could expand treatment possibilities for complex sarcoma cases.
- Further research is warranted to confirm safety and efficacy in larger patient cohorts.